Overview
- 4 inspections across 4 sites are on record.
- 10 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2024-08-29.
At a glance
Inspections
4
Sites
4
Observations
10
Career since
Jul 2017
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Novo Nordisk Pharmaceutical Industries LP | 29 Aug 2024 | Human Drugs | View 483 → |
| Pfizer Manufacturing Deutschland GmbH | 7 Feb 2020 | Human Drugs | On file |
| Pfizer, Inc. | 18 Jul 2018 | Human Drugs | View 483 → |
| Neos Therapeutics, LP | 25 Jul 2017 | Human Drugs | On file |
Sites inspected
Novo Nordisk Pharmaceutical Industries LPDurham, United States1 insp.
Pfizer Manufacturing Deutschland GmbHFreiburg Im Breisgau, Germany1 insp.
Pfizer, Inc.Groton, United States1 insp.
Neos Therapeutics, LPGrand Prairie, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Sarah C Zimmermann1 shared
James Norman1 shared
Marian E Ramirez1 shared
Simone E Pitts1 shared
Wei-Hua Wu1 shared
Thomas J Arista1 shared
Niketa Patel1 shared
Hang N Guo1 shared
Rapti D Madurawe1 shared
Edmund F Mrak1 shared
Full investigator report
Get the verbatim findings behind Chunsheng Cai's 10 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site